Depomed Sues Banner, Watson Over Proposed Generic Zipsor
Banner's abbreviated new drug application for generic 25 milligram diclofenac potassium tablets will infringe five patents that protect its Zipsor drug, according to Depomed. Watson is the exclusive licensee of the generic drug candidate, the complaint says.
Banner notified Depomed in a letter June 27 that it filed the...
To view the full article, register now.